ORANGE Study

ORal ANticoagulant aGEnt associated bleeding events reporting system study

The ORANGE study is appealing to healthcare professionals for their participation. It is a three year prospective observational study collecting data on the management and clinical outcome of patients who develop major bleeding whilst on oral anticoagulants (OACs) across the UK. It is sponsored by Queen Mary University of London and funded by the British Society for Haematology.

The ORANGE study is recruiting clinicians to take part in the study until 31 December 2016. There are currently 11 hospitals across the UK participating in the study and we are open to new sites.

If you would like to find out more about the study, or are interested in joining, please contact

The Study Coordinator

at BHNT.Orangestudy@nhs.net.

 

For more details, click here